MGNX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MacroGenics Inc (MGNX) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators show an overbought condition with a high RSI, and while the MACD is positive, the financial performance is weak with significant YoY declines in revenue, net income, and EPS. Additionally, there are no significant positive catalysts or strong trading signals to support a buy decision. The options data indicates low put-call ratios, but this alone does not justify a buy given the overall weak fundamentals and lack of clear growth drivers.
The stock is currently in an overbought condition with RSI_6 at 80.206. The MACD histogram is positive at 0.0345 and expanding, suggesting bullish momentum. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance is at 2.119 and 2.257, while support levels are at 1.673 and 1.535.
NULL identified. The stock has no significant news or events driving positive sentiment. The options market shows low put-call ratios, indicating limited bearish sentiment.
The company's financial performance is weak, with significant YoY declines in revenue (-34.21%), net income (-70.13%), and EPS (-70.00%). Gross margin also dropped by 14.46%. No recent insider or hedge fund activity indicates strong interest in the stock.
In Q3 2025, revenue dropped to $72.84M (-34.21% YoY), net income fell to $16.82M (-70.13% YoY), and EPS decreased to 0.27 (-70.00% YoY). Gross margin declined to 84.09 (-14.46% YoY).
No recent analyst rating or price target changes available for MGNX.
